• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dexcom, UnitedHealth team up for wearable glucose management pilot program

January 12, 2018 By Sarah Faulkner

Dexcom, UnitedHealthcareUpdated Jan. 17 to include confirmation of Fitbit’s participation.

UnitedHealth (NYSE:UNH) and Dexcom (NSDQ:DXCM) are joining forces to launch an individualized glucose management pilot program to help people with Type II diabetes manage their condition in real-time using wearable tech.

People using UnitedHealth’s Medicare Advantage plan are eligible to use Dexcom’s mobile continuous glucose monitoring system to track their blood sugar levels. Participating in the program also gives people access to personalized diabetes coaching and an activity tracker, the companies reported this week.

“With more than 27 million people nationwide living with Type II diabetes there is urgent need to address this epidemic in new ways,” Brian Thompson, CEO of UnitedHealthcare Medicare & Retirement, said in prepared remarks.

“Continuous glucose monitoring can be a game changer for people enrolled in our Medicare Advantage plans, as the data can be translated into personalized information that can be acted upon in real time.”

“Dexcom is thrilled to work with UnitedHealthcare to bring this program to people living with diabetes,” Steve Pacelli, Dexcom’s EVP of strategy and corporate development, added. “The insights that CGM and this program provide can drive significant value to both patients and care providers in helping to better manage diabetes.”

The pilot was showcased this week at the International Consumer Electronics Show in Las Vegas. Reporting from the conference, The Verge’s senior technology editor Lauren Goode wrote on Twitter that Dexcom and UnitedHealth are working with Fitbit (NYSE:FIT) as part of the program.

A spokesperson for Fitbit confirmed the company’s involvement in the pilot program, writing in an email that “participation in the program demonstrates Fitbit’s commitment to providing new tools and insights to support the diabetes community, which is an important area of focus for the company and one where we believe there is an opportunity to help drive better health outcomes.”

Dexcom and Fitbit have an existing partnership to incorporate Dexcom’s CGM tech into Fitbit’s latest smartwatch, the Fitbit Ionic.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, Patient Monitoring, Wall Street Beat Tagged With: DexCom Inc., fitbit, unitedhealth

IN CASE YOU MISSED IT

  • BD stock up on Street-beating preliminary quarterly revenue numbers
  • Locate Bio lands FDA breakthrough nod for bone infection device
  • PerkinElmer to acquire Oxford Immunotec
  • Evonik buys polymers business from Durect Corp.
  • New Croatian notified body designated to European MDR

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS